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A B S T R A C T
Hair testing for drugs of abuse is a developing technology, which offers the possibility
of longer detection times than is commonly obtained with urine analysis. It is the main
method for evaluation of an individual’s drugs of abuse history. In many countries hair
analysis is routinely used to detect drug abuse in forensic cases, occupational and traffic
medicine and clinical toxicology. Hair analysis in pregnant women, neonates and in-
fants is a useful tool for the detection of drug exposure in utero. In Croatia hair testing
for drugs of abuse is performed at the Institute for Medical Research and Occupational
Health. Three-year experience in drugs of abuse analysis in hair is described. In 331
hair samples (270 from adolescents and 61 from adults) opiates and metabolites, co-
caine, methadone, and amphetamines were analyzed by gas chromatography/mass
spectrometry. Most prevalent drugs of abuse in adolescents were amphetamines, and in
adults heroin. From the examples cited and samples analyzed it is evident that hair
testing is emerging as a reliable biological marker for cumulative account of individual
exposure to drugs of abuse.
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Introduction
The prevalence of drug consumption in
Europe
Consumption of drugs of abuse is
growing and threatens to be a problem to
the whole of humanity. An estimation of
the proportion of the population that uses
drugs, or that experimented with them, is
basic information needed to assess the
drug situation, to develop policies and to
evaluate them. It is necessary to know in
which group’s drug use is concentrated
and the patterns of use. According to the
annual report on the European Union
drugs problem 1 drug use is highest in It-
aly, Luxembourg, Portugal and the UK,
and lowest in Belgium, Germany and the
Netherlands, respectively. Cannabis re-
mains the illegal drug most commonly
used in all EU countries. About 15% of
the population in Finland and Sweden,
and 28–40% in Denmark, Spain, France,
Ireland, the Netherlands, and the UK
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took cannabis. Up to 4% of EU adults,
and 8% of 15–16 year old young people
used amphetamines including »Ecstasy«.
Cocaine has been experienced by 0.5 to
3%. Although less than one in 100 adults
reports heroin use – it causes most prob-
lems (infectious disease, overdose).
For most drugs young adults (aged 15
to 34) present rates up to double the adult
population. Perceived access to drugs by
15 to 16 year-old students increased in
the period from 1995 to 1999 in all partic-
ipating EU countries, except Ireland and
the UK, where it decreased. In central
and east European countries1 (Croatia ex-
cluded) an increase in the experience of
illicit drug use among school children (15
to 16 years old) was reported in 2000.
This increase reflects mostly the use of
cannabis, the commonest drug used among
teenagers.
In the last 10 years the number of il-
licit drug addicts in Croatia2 has almost
trebled. The situation is most serious in
the coastal area: data for 1999 indicate
around 1,500 new drug addicts per year,
of whom 85% are heroin addicts.
Identification of drug use
Recognizing drug abuse as a major
problem world-wide, a number of rapid
commercial immunoassay techniques for
drugs of abuse testing in urine have been
developed. Their results are satisfactory
only for the first step in differentiating
negative and positive urine samples. Rec-
ommended analytical protocol demands
confirmation of the positive samples by a
more specific technique, usually chroma-
tographic3. However, sampling time of
urine is critical because drugs, with the
exception of marihuana, can be detected
in urine 2 to 3 days after consumption4.
Urine testing provides a reliable answer
for short- term recent exposure. However,
there is a need for a biological marker,
which may yield a cumulative reflection
of long-term exposure to illicit drugs.
Hair analysis is a reliable tool for proving
or excluding chronic drug abuse5–8. Hair
is particularly advantageous as a biologi-
cal matrix: it can be easily obtained with-
out violating individual privacy, it is not
easily adulterated, and it can be stored
and transported without special precau-
tions, due to its stability. Studies on Egy-
ptian mummies9 have provided evidence
of the long-term stability of drugs in hair
samples.
In 1979 Baumgartner et al.10 first de-
tected morphine in hair. Since then a
great number of papers on hair testing for
drugs of abuse has been published11–16.
Normal hair grows in stages: the anagen
(growing) stage; the catagen (transition),
and telogen (resting) phase. The growth
speed varies from 0.8 to 1.3 cm/month17
and thus the history of drug abuse can be
traced months back, depending on the
length of the hair. There are many uncer-
tainties concerning how drugs enter hair
and factors that affect drug deposition
and residence in hair. Possible routes of
drug entry include diffusion from blood,
sweat, sebum and skin and entry from
the environment (contamination, passive
exposure). Very little is known about the
potential for environmental contamina-
tion of hair by drugs of abuse. It has been
indicated that cocaine is adsorbed by hair
when the cocaine base is vaporized in the
presence of drug-free hair18,19.
Washing techniques for the removal of
cocaine from contaminated hair vary wi-
dely in reported efficiency20. Generally,
appropriate decontamination procedures
and the necessity of hair dissolution for
adequate drug recovery are very impor-
tant.
Several authors recently published re-
sults about a decreasing tendency of the
hair drug content because of cosmetic treat-
ment21–24. Bleaching, coloring, or perma-
nent waving were found to affect the sta-
bility of incorporated drugs and to cause
alterations of the fibers at an ultra-struc-
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tural level. This may result in partial or
complete loss of drug substances, depend-
ing on the particular drug molecule and
on its concentration prior to cosmetic
treatment.
The results of a few studies25,26 have
indicated the influence of hair pigmenta-
tion on the drug content in the hair fi-
bers, i.e. there are differences between
white, black, and Asian hair types.
As most hair in the posterior vertex
area (85%) is in an active growing phase,
and thus more likely to incorporate a
drug, this region of the scalp is generally
chosen as the sampling site. When head
hair is not available or too short pubic or
axillary hair is collected for drugs of abu-
se analysis27.
Sectional analysis i.e. the analysis of
hair segments is occasionally used, but
shows little correlation between the time
of drug administration and the position of
the drug along the hair shaft28. Also, cor-
relation between the drug dose and the
amount of drug and metabolites found in
hair is unclear at the present time and re-
mains controversial14–16. Therefore, hair
analysis for drugs of abuse reveals chro-
nic drug consumption, but does not re-
flect the drug dose and time of drug ad-
ministration.
Applicability of drug hair analysis
In some European countries hair anal-
ysis is routinely used as a tool of detection
for drug abuse in forensic sciences29, traf-
fic medicine30, occupational medicine and
clinical toxicology4,31. In some of them
testing of human hair is accepted by the
Courts of Justice32. In forensic medicine
hair can be used as a »calendar« of past
exposure. Information concerning the
abuse pattern of a subject in the weeks or
months before death can be of the highest
relevance for the forensic pathologist
when the autopsy findings are unremark-
able and the concentrations of drugs in
blood are low29. Today hair testing is also
applied in several areas of criminal in-
vestigation33. A person taken into custody
for drug trafficking with no drugs de-
tected in the hair will be sentenced as a
dealer; with drugs detected in the hair
such a person could be treated as an ad-
dict and be guaranteed extenuating cir-
cumstances34.
Hair analysis from pregnant woman,
neonates and infants has been shown to
be a useful tool for the detection of drug
exposure in utero35–38. Because the neo-
natal hair grows during the last 3 to 4
months of gestation, the presence of drugs
may be an indicator of cumulative levels
over the last trimester.
In university student’s hair analysis
was performed to evaluate the incidence
of drug abuse39.
Hair analysis can also help clinicians
to decide whether the use of illicit substan-
ces (cannabinoids, amphetamines) has con-
tributed to the etiology of psychosis or not40.
Experience of hair drug analysis in
Croatia
In Croatia hair testing for drugs of
abuse is at the moment not referred to
any law or decision of the government.
Hair testing for drugs of abuse has
been performed only in the Clinical-Toxi-
cological Chemistry Unit at the Institute
for Medical Research and Occupational
Health. Gas chromatographic/mass spec-
trometric (GC/MS) methods have been
developed for the determination of opi-
ates (morphine, codeine, heroin, and 6-ace-




thamphetamine, MDMA, »Ecstasy«, and
3,4-methylenedioxyethylamphetamine,
MDEA) in hair41. For analysis hair sam-
ples, approximately 0.5 cm in diameter,
were cut as close as possible to the scalp
of the vertex posterior area, folded in alu-
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minum foil, and the proximal and distal
ends marked. Samples 2 to 4 cm long
were analyzed, which represent approxi-
mately 2 to 4 months growth. It was not
possible to analyze all drugs and metabo-
lites simultaneously. They were divided
into two groups; I. (morphine, codeine,
heroin, 6-acetylmorphine, methadone, and
cocaine), and II. (amphetamines). The
methods included hair washing, cutting,
extraction, derivatization, and GC/MS de-
termination. It was decided to wash hair
samples in dichlormethane twice, becau-
se tests showed that the third wash was
always negative, although the two previ-
ous washes were positive. After washing,
the hair was dried and cut into very small
pieces of less than 1 mm, and 50 mg of
each sample was analyzed. Methanol was
chosen for extracting opiates and cocaine.
The best recoveries for amphetamines
were obtained after alkaline hydrolysis of
hair. Hair samples for morphine, codeine,
heroin, 6-acetylmorphine, methadone, and
cocaine determination were cleaned up
by solid-phase extraction, and for am-
phetamines by liquid extraction (ethyl ac-
etate). A variety of derivatization reagents
are used in the analysis of drugs of abuse.
For the analysis it was found that a mix-
ture of propionic acid anhydride and py-
ridine was very convenient and superior
to N, O-bis(trimethylsilyl)trifluoroaceta-
mide with 1% trimethylchlorosilane for
the derivatization of codeine, 6-acetyl
-morphine, and morphine. Heptafluoro-
butyric anhydride is recommended for the
derivatization of amphetamines.
Methods were analytically validated
for sensitivity, reproducibility, and accu-
racy. External quality assessment was
verified through participation in the pro-
gram Proficiency Test on Drugs of Abuse
in Hair Testing, Munich, Germany.
The developed methods were applied
in the hair analysis of 331 subjects (107
females; 224 males) who were suspected
of drug abuse. A large majority of subjects
(n=270; 14 to 19 years) were adolescents
and the other subjects (n=61; 19 to 27
years) were adults. Their parents, older
sister, brother, or other relative who wi-
shed to remain anonymous mostly accom-
panied them. For that reason the hair
samples were identified only by first or a
fictitious name, or by a number. Often
hair samples were taken according to our
instruction and either brought to the Unit
or sent by the regional drug abuse pre-
vention centers.
Only 101 samples (24 females, 77 ma-
les) were positive for drugs of abuse, and
230 were found negative. Although the
low percent of positive results is rather
unexpected, there is a plausible explana-
tion. Namely, most hair samples were
taken from young people whose parents
were upset by their change in behavior
and poor results in school or university,
which lead them to suspect that their
children were taking drugs. This suspi-
cion was not altogether unjustified as
most of them smoked marihuana3. How-
ever, a method has not yet been devel-
oped for the analysis of marihuana's psy-
choactive constituent tetrahydrocannabi-
nol in hair.
Table 1 summarizes positive results of
drugs of abuse (n=101) in which one or
more than one kind of drug were found,
and Table 2 shows the concentrations
(range and median) of analyses found in
drug consumers’ hair.
In most subjects amphetamines were
found alone (n=48) or with other drugs
(n=6). The results of the hair analysis in-
dicate that the leading amphetamine was
MDMA (n=46), which confirmed »Ecsta-
sy« consumption. »Ecstasy« is believed to
be popular as a »dance drug« among the
young; particularly those who attend »ra-
ve parties«. Opiates alone were measured
in 20 hair samples, and with other drugs
in 17 hair samples. The only specific her-
oin metabolite 6-acetylmorphine was found
in all these samples confirming heroin
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consumption. Cocaine was present in 16
hair samples, in four alone; and metha-
done in 21 hair samples, in seven alone.
Apart from the living, hair samples
(from the head and pubic regions) were
also analyzed from dead persons suspec-
ted of drug overdose. In heroin consumers
the 6-acetylmorphine concentration was
always higher in pubic than in head hair
and ranged from 1.10 to 23.08 ng/mg and
0.72 to 9.05 ng/mg, respectively.
In some cases hair was tested for drug
abuse under special circumstances, when
urine tests were not informative. Only by
hair analysis for opiates is it possible to
distinguish administration of pharmace-
utical products (codeine, pholcodine), in-
gestion of poppy seed food (morphine, co-
deine), and true drug abuse (heroin, mor-
phine). Namely, the only specific heroin
metabolite 6-acetylmorphine is always
present in the hair of heroin consumers,
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TABLE 1
POSITIVE HAIR SAMPLES (N=101) FOR PARTICULAR DRUGS AND COMBINATION OF DRUGS













THE CONCENTRATIONS OF PARTICULAR ANALYTES FOUND IN DRUG CONSUMERS’
HAIR SAMPLES




Amphetamine 16 0.37–16.35 2.43
Methamphetamine 7 0.30–2.01 0.60
MDA 7 0.18–1.81 0.74
MDMA 46 0.56–64.42 2.04
MDEA –
Heroin 21 0.27–63.57 2.20
6-Acetylmorphine 7 0.57–32.21 2.11
Morphine 28 0.56–5.05 1.10
Codeine 15 0.25–3.30 1.29
Cocaine 16 1.15–7.91 2.84
Methadone 21 1.12–55.70 5.20
but not in people who take analgesics
with codeine or eat poppy seed cake42.
From both the literature examples
and results in the Unit it is evident that
hair testing is emerging as a reliable bio-
logical marker for cumulative account of
exposure to drugs of abuse. However, there
are some pitfalls that must be taken into
account in interpretation of the hair test-
ing for drugs of abuse.
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PROCJENA ZLOUPORABE DROGA ANALIZOM KOSE
S A @ E T A K
U novije vrijeme kosa kao biolo{ki uzorak za analizu droga dobiva sve ve}i zna~aj.
Za razliku od urina analiza kose pro{iruje mogu}nost detekcije droga na mjesece, ovi-
sno o duljini kose. Analiza droga u kosi u razvijenim zemljama koristi se u sudskoj
medicini, medicini rada, pri prometnim prekr{ajima, kriminalnim slu~ajevima te u kli-
ni~koj toksikologiji. U novoro|en~adi se analizom kose utvr|uje je li majka za vrijeme
trudno}e uzimala drogu. U Hrvatskoj se uzimanje droga analizom kose odre|uje jedino
u Institutu za medicinska istra`ivanja i medicinu rada. Razvijene su metode za anali-
zu opijata i metabolita, kokaina, metadona i amfetamina tehnikom plinske kromato-
grafije sa spektrometrijom masa. Tijekom tri godine analiziran je 331 uzorak kose; 270
od adolescenata i 61 od odraslih osoba. U adolescenata je naj~e{}e uzimana droga iz
skupine amfetamina, dok odrasle osobe naj~e{}e uzimaju heroin. Na temelju opisanih
primjera iz literature i vlastitog iskustva mo`e se zaklju~iti da je kosa dobar biolo{ki
pokazatelj za procjenu ponavljanog/kroni~nog uzimanja droga.
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